Biojoint 50mg Tablet
By Biojoint
Rx
10 Tablet in a Strip

Composition
Diacerein(50mg)

Manufacturer - Elfin Pharma Pvt Ltd
Elfin , E-206, Industrial Area, Phase 8 B, S.A.S. Nagar, Mohali, India

Expires on or after
August, 2025

liver
Biojoint 50mg Tablet is not recommended for use in individuals with liver disease. It is important to consult your doctor before taking this medication if you have any liver issues. Using Biojoint 50mg Tablet in patients with liver disease is considered unsafe, so it should be avoided to prevent any potential complications. Always seek guidance from your healthcare provider regarding the safety of using this medicine if you have liver problems.

kidney
Biojoint 50mg Tablet is considered safe for patients with kidney disease. Limited data indicates that adjusting the dose may not be necessary. Consult your doctor for guidance.

alcohol
It is important to be cautious when consuming alcohol while taking Biojoint 50mg Tablet. Consult your doctor before combining alcohol with this medication.

driving
It is not known if Biojoint 50mg Tablet affects driving ability. Avoid driving if you have symptoms that impact concentration or reaction time.

pregnancy
Biojoint 50mg Tablet is generally safe during pregnancy, with minimal adverse effects on the baby based on animal studies. Limited human studies available.

breastfeeding
Biojoint 50mg Tablet is considered safe for use while breastfeeding. Limited human studies indicate no significant risk to the baby.
Habit Forming | No |
Chemical Class | Anthracenecarboxylic Acids |
Therapeutic Class | PAIN ANALGESICS |
Action Class | Proteoglycan synthesis Stimulator |
₹89
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025